PROTEIN-BINDING AND CSF PENETRATION OF PHENYTOIN FOLLOWING ACUTE ORAL DOSING IN MAN

被引：18

作者：

BRODIE, MJ ^{[1
]}

MUIR, SE ^{[1
]}

AGNEW, E ^{[1
]}

MACPHEE, GJA ^{[1
]}

VOLO, G ^{[1
]}

TEASDALE, E ^{[1
]}

MACPHERSON, P ^{[1
]}

机构：

[1] SO GEN HOSP,DEPT NEURORADIOL,GLASGOW G51 4TF,SCOTLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 19卷 / 02期

关键词：

D O I：

10.1111/j.1365-2125.1985.tb02627.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：161 / 168

页数：8

共 23 条

[11] PLASMA-PROTEIN BINDING OF PHENYTOIN IN 100 EPILEPTIC PATIENTS [J].

PETERSON, GM ;

MCLEAN, S ;

ALDOUS, S ;

VONWITT, RJ ;

MILLINGEN, KS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :298-300

[12] PLASMA PROTEIN-BINDING AND CSF CONCENTRATIONS OF VALPROIC ACID IN MAN FOLLOWING ACUTE ORAL DOSING [J].

RAPEPORT, WG ;

MENDELOW, AD ;

FRENCH, G ;

MACPHERSON, P ;

TEASDALE, E ;

AGNEW, E ;

THOMPSON, GG ;

BRODIE, MJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (04) :365-369

[13] CHRONIC ANTIEPILEPTIC TOXICITY - REVIEW [J].

REYNOLDS, EH .

EPILEPSIA, 1975, 16 (02) :319-352

[14]

RICHENS A, 1975, LANCET, V2, P247

[15] CLINICAL PHARMACOKINETICS OF PHENYTOIN [J].

RICHENS, A .

CLINICAL PHARMACOKINETICS, 1979, 4 (03) :153-169

[16]

RICHENS A, 1981, THERAPEUTIC DRUG MON, P320

[17] SHOULD WE ROUTINELY MEASURE FREE PLASMA PHENYTOIN CONCENTRATION [J].

RIMMER, EM ;

BUSS, DC ;

ROUTLEDGE, PA ;

RICHENS, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (01) :99-102

[18] PLASMA-PROTEIN BINDING AND THERAPEUTIC DRUG-MONITORING [J].

ROWLAND, M .

THERAPEUTIC DRUG MONITORING, 1980, 2 (01) :29-37

[19] INFLUENCE OF DH-DL ALLELES REGULATING DEBRISOQUINE OXIDATION ON PHENYTOIN HYDROXYLATION [J].

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (04) :493-497

[20]

TEASDALE E, 1984, BR J RADIOL

← 1 2 3 →